{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:55:59Z","timestamp":1790837759155,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["CCBY"],"award-info":[{"award-number":["CCBY"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12032-018-1104-9","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T22:39:42Z","timestamp":1519771182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The inhibition of invasion of human melanoma cells through N-cadherin knock-down"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2631-7308","authenticated-orcid":false,"given":"Dorota","family":"Cio\u0142czyk-Wierzbicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Laidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"issue":"13A","key":"1104_CR1","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/j.1460-2075.1985.tb04095.x","volume":"4","author":"D Vestweber","year":"1985","unstructured":"Vestweber D, Kemler R. Identification of a putative cell adhesion domain of uvomorulin. EMBO J. 1985;4(13A):3393\u20138.","journal-title":"EMBO J"},{"issue":"7196","key":"1104_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nature06953","volume":"453","author":"M Cavey","year":"2008","unstructured":"Cavey M, Rauzi M, Lenne PF, Lecuit T. A two-tiered mechanism for stabilization and immobilization of E-cadherin. Nature. 2008;453(7196):751\u20136.","journal-title":"Nature"},{"issue":"7327","key":"1104_CR3","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nature09566","volume":"468","author":"M Rauzi","year":"2010","unstructured":"Rauzi M, Lenne PF, Lecuit T. Planar polarized actomyosin contractile flows control epithelial junction remodelling. Nature. 2010;468(7327):1110\u20134.","journal-title":"Nature"},{"issue":"1","key":"1104_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1073\/pnas.91.1.206","volume":"91","author":"MS Steinberg","year":"1994","unstructured":"Steinberg MS, Takeichi M. Experimental specification of cell sorting, tissue spreading, and specific spatial patterning by quantitative differences in cadherin expression. Proc Natl Acad Sci USA. 1994;91(1):206\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1104_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1158\/1541-7786.MCR-10-0139","volume":"8","author":"M Yilmaz","year":"2010","unstructured":"Yilmaz M, Christofori G. Mechanisms of motility in metastasizing cells. Mol Cancer Res. 2010;8:629\u201342.","journal-title":"Mol Cancer Res"},{"key":"1104_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.tcb.2011.05.006","volume":"21","author":"GA Gomez","year":"2011","unstructured":"Gomez GA, McLachlan RW, Yap AS. Productive tension: force-sensing and homeostasis of cell\u2013cell junctions. Trends Cell Biol. 2011;21:499\u2013505.","journal-title":"Trends Cell Biol"},{"key":"1104_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ceb.2011.08.003","volume":"23","author":"D Leckband","year":"2011","unstructured":"Leckband D, leDuc Q, Wang N, deRooij J. Mechanosensing at cadherin adhesions. Curr Opin Cell Biol. 2011;23:523\u201330.","journal-title":"Curr Opin Cell Biol"},{"key":"1104_CR8","doi-asserted-by":"publisher","first-page":"35593","DOI":"10.1074\/jbc.R600027200","volume":"281","author":"WI Weis","year":"2006","unstructured":"Weis WI, Nelson WJ. Re-solving the cadherin-catenin-actin conundrum. J Biol Chem. 2006;281:35593\u20137.","journal-title":"J Biol Chem"},{"issue":"19","key":"1104_CR9","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1074\/jbc.M114.554709","volume":"289","author":"S Pokutta","year":"2014","unstructured":"Pokutta S, Choi H, Ahlsen G, Hansen SD, Weis WI. Structural and thermodynamic characterization of cadherin center dot beta-catenin center dot alpha-catenin complex formation. J Biol Chem. 2014;289(19):13589\u2013601.","journal-title":"J Biol Chem"},{"key":"1104_CR10","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0002-9440(10)65023-7","volume":"156","author":"M Hsu","year":"2000","unstructured":"Hsu M, Meier F, Nesbit M, Hsu J, Belle P, Elder D, Herlyn M. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol. 2000;156:1515\u201325.","journal-title":"Am J Pathol"},{"key":"1104_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1387\/ijdb.041793ld","volume":"48","author":"LD Derycke","year":"2004","unstructured":"Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signaling. Int J Dev Biol. 2004;48:463\u201376.","journal-title":"Int J Dev Biol"},{"issue":"3","key":"1104_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/CEJ.0b013e3283429e8b","volume":"20","author":"K Jacobs","year":"2011","unstructured":"Jacobs K, Feys L, Vanhoecke B, Van Marck V, Bracke M. P-cadherin expression reduces melanoma growth, invasion, and responsiveness to growth factors in nude mice. Eur J Cancer Prev. 2011;20(3):207\u201316.","journal-title":"Eur J Cancer Prev"},{"issue":"12","key":"1104_CR13","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/bjc.2011.452","volume":"105","author":"K Araki","year":"2011","unstructured":"Araki K, Shimura T, Suzuki H, Tsutsumi S, Wada W, Yajima T, Kobayahi T, Kubo N, Kuwano H. E\/N-cadherin switch mediates cancer progression via TGF-\u03b2-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer. 2011;105(12):1885\u201393.","journal-title":"Br J Cancer"},{"key":"1104_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.advenzreg.2010.09.005","volume":"51","author":"D Gil","year":"2011","unstructured":"Gil D, Cio\u0142czyk-Wierzbicka D, Duli\u0144ska-Litewka J, \u017bwawa K, McCubrey JA, Laidler P. The mechanism of contribution of integrin linked kinase (ILK) to epithelial mesenchymal transition (ETM). Adv Enzyme Regul. 2011;51:195\u2013207.","journal-title":"Adv Enzyme Regul"},{"key":"1104_CR15","doi-asserted-by":"publisher","first-page":"15185","DOI":"10.1007\/s13277-016-5354-x","volume":"37","author":"D Gil","year":"2016","unstructured":"Gil D, Cio\u0142czyk-Wierzbicka D, Duli\u0144ska-Litewka J, et al. Integrin-linked kinase regulates cadherin switch in bladder cancer. Tumor Biol. 2016;37:15185. \n                    https:\/\/doi.org\/10.1007\/s13277-016-5354-x\n                    \n                  .","journal-title":"Tumor Biol"},{"issue":"1","key":"1104_CR16","doi-asserted-by":"publisher","first-page":"e55069","DOI":"10.1371\/journal.pone.0055069","volume":"8","author":"Y Cui","year":"2013","unstructured":"Cui Y, Yamada S. N-cadherin dependent collective cell invasion of prostate cancer cells is regulated by the N-terminus of \u03b1-catenin. PLoS ONE. 2013;8(1):e55069. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0055069\n                    \n                  .","journal-title":"PLoS ONE"},{"issue":"8","key":"1104_CR17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","volume":"13","author":"J Westermarck","year":"1999","unstructured":"Westermarck J, K\u00e4h\u00e4ri VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999;13(8):781\u201392.","journal-title":"FASEB J"},{"issue":"3","key":"1104_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/01.cmr.0000215033.92693.73","volume":"16","author":"YG Shellman","year":"2006","unstructured":"Shellman YG, Makela M, Norris DA. Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res. 2006;16(3):207\u201311.","journal-title":"Melanoma Res"},{"issue":"5","key":"1104_CR19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s10517-013-2007-6","volume":"154","author":"MB Aksenenko","year":"2013","unstructured":"Aksenenko MB, Ruksha TG. Analysis of the application of MMP-9 inhibitor in skin melanoma. Bull Exp Biol Med. 2013;154(5):594\u20136.","journal-title":"Bull Exp Biol Med"},{"issue":"3","key":"1104_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10517-012-1717-5","volume":"153","author":"MB Aksenenko","year":"2012","unstructured":"Aksenenko MB, Gyrylova SN, Ruksha TG. Changes in the levels of N-cadherin and PCNA in skin melanoma cells are mediated through matrix metalloproteinase 9. Bull Exp Biol Med. 2012;153(3):364\u20136.","journal-title":"Bull Exp Biol Med"},{"key":"1104_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1196\/annals.1294.016","volume":"1014","author":"RB Hazan","year":"2004","unstructured":"Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci. 2004;1014:155\u201363.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1104_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/onc.2012.25","volume":"32","author":"J Ferguson","year":"2013","unstructured":"Ferguson J, Arozarena I, Ehrhardt M, Wellbrock C. Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion. Oncogene. 2013;32(1):86\u201396.","journal-title":"Oncogene"},{"issue":"1","key":"1104_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2174\/092986712803414006","volume":"19","author":"D Cio\u0142czyk-Wierzbicka","year":"2012","unstructured":"Cio\u0142czyk-Wierzbicka D, Gil D, Laidler P. The inhibition of cell proliferation using silencing of N-cadherin gene by siRNA process in human melanoma cell lines. Curr Med Chem. 2012;19(1):145\u201351.","journal-title":"Curr Med Chem"},{"issue":"7","key":"1104_CR24","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1158\/0008-5472.CAN-06-3401","volume":"67","author":"J Hulit","year":"2007","unstructured":"Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W, Dong X, Williams TM, Lisanti MP, Knudsen K, Hazan RB. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res. 2007;67(7):3106\u201316.","journal-title":"Cancer Res"},{"issue":"3","key":"1104_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1440-1827.2011.02774.x","volume":"62","author":"T Kamikihara","year":"2012","unstructured":"Kamikihara T, Ishigami S, Arigami T, Matsumoto M, Okumura H, Uchikado Y, Kita Y, Kurahara H, Kijima Y, Ueno S, Natsugoe S. Clinical implications of N-cadherin expression in gastric cancer. Pathol Int. 2012;62(3):161\u20136.","journal-title":"Pathol Int"},{"key":"1104_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ijo.2015.3270","volume":"48","author":"M Wang","year":"2016","unstructured":"Wang M, Ren D, Guo W, Huang S, Wang Z, Li Q, Du H, Song L, Peng X. N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells. Int J Oncol. 2016;48:595\u2013606.","journal-title":"Int J Oncol"},{"issue":"10","key":"1104_CR27","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/bjc.2015.358","volume":"113","author":"C Siret","year":"2015","unstructured":"Siret C, Terciolo Ch, Dobric A, Habib M, Germain S, Bonnier R, Lombardo D, Rigot V. Andr\u00e91 F. Interplay between cadherins and \u03b12\u03b21 integrin differentially regulates melanoma cell invasion. Br J Cancer. 2015;113(10):1445\u201353.","journal-title":"Br J Cancer"},{"key":"1104_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1242\/jcs.000455","volume":"121","author":"MJ Wheelock","year":"2008","unstructured":"Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci. 2008;121:727\u201335.","journal-title":"J Cell Sci"},{"key":"1104_CR29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases structure, function, and biochemistry. Circ Res. 2003;92:827\u201339.","journal-title":"Circ Res"},{"key":"1104_CR30","doi-asserted-by":"publisher","unstructured":"Pires I, Gomes J, Prada J, Pereira D, Queiroga FL. MMP-2 and MMP-9 expression in canine cutaneous melanocytic tumours: evidence of a relationship with tumoural malignancy. Melanoma\u2014from early detection to treatment\/Book 2. 2013; Intech. pp. 1\u201329. \n                    https:\/\/doi.org\/10.5772\/54878\n                    \n                  .","DOI":"10.5772\/54878"},{"issue":"9","key":"1104_CR31","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bjc.2012.80","volume":"106","author":"AMJ Langers","year":"2012","unstructured":"Langers AMJ, Verspaget HW, Hawinkels LJAC, Kubben FJGM, van Duijn W, van der Reijden JJ, Hardwick JCH, Hommes DW, Sier CFM. MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients. Br J Cancer. 2012;106(9):1495\u20138. \n                    https:\/\/doi.org\/10.1038\/bjc.2012.80\n                    \n                  .","journal-title":"Br J Cancer"},{"key":"1104_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fonc.2013.00252","volume":"3","author":"DE Dye","year":"2013","unstructured":"Dye DE, Medic S, Ziman M, Coombe DR. Melanoma biomolecules: independently identified but functionally intertwined. Front Oncol. 2013;3:252. \n                    https:\/\/doi.org\/10.3389\/fonc.2013.00252\n                    \n                  .","journal-title":"Front Oncol"},{"key":"1104_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/185687","author":"R Ria","year":"2010","unstructured":"Ria R, Reale A, Castrovilli A, Mangialardi G, Dammacco F, Ribatti D, Vacca A. Angiogenesis and progression in human melanoma. Dermatol Res Pract. 2010. \n                    https:\/\/doi.org\/10.1155\/2010\/185687\n                    \n                  .","journal-title":"Dermatol Res Pract"},{"issue":"1","key":"1104_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbamcr.2009.04.010","volume":"1803","author":"N Sela-Passwell","year":"2010","unstructured":"Sela-Passwell N, Rosenblum G, Shoham T, Sagi I. Structural and functional bases for allosteric control of MMP activities: Can it pave the path for selective inhibition? Biochim Biophys Acta BBA Mol Cell Res. 2010;1803(1):29\u201338. \n                    https:\/\/doi.org\/10.1016\/j.bbamcr.2009.04.010\n                    \n                  .","journal-title":"Biochim Biophys Acta BBA Mol Cell Res"},{"issue":"4","key":"1104_CR35","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3892\/ijo.2014.2549","volume":"45","author":"A Walker","year":"2014","unstructured":"Walker A, Frei R, Lawson K. The cytoplasmic domain of N-cadherin modulates MMP-9 induction in oral squamous carcinoma cells. Int J Oncol. 2014;45(4):1699\u2013706.","journal-title":"Int J Oncol"},{"issue":"16","key":"1104_CR36","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12885-016-2846-4","volume":"13","author":"CC Hsu","year":"2016","unstructured":"Hsu CC, Huang SF, Wang JS, Chu WK, Nien JE, Chen WS, Chow SE. Interplay of N-cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion. BMC Cancer. 2016;13(16):800. \n                    https:\/\/doi.org\/10.1186\/s12885-016-2846-4\n                    \n                  .","journal-title":"BMC Cancer"},{"issue":"1","key":"1104_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12974-017-0827-4","volume":"14","author":"K Conant","year":"2017","unstructured":"Conant K, Daniele S, Bozzelli PL, Abdi T, Edwards A, Szklarczyk A, Olchefske I, Ottenheimer D, Maguire-Zeiss K. Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation. J Neuroinflamm. 2017;14(1):56\u201370. \n                    https:\/\/doi.org\/10.1186\/s12974-017-0827-4\n                    \n                  .","journal-title":"J Neuroinflamm"},{"issue":"8","key":"1104_CR38","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-12-3476","volume":"19","author":"F Catalanotti","year":"2013","unstructured":"Catalanotti F, Solit DB, Pulitzer MP, Berger MF, Scott SN, Iyriboz T, Lacouture ME, Panageas KS, Wolchok JD, Carvajal RD, Schwartz GK, Rosen N, Chapman PB. Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E\/K-Mutated Melanoma. Clin Cancer Res. 2013;19(8):2257\u201364.","journal-title":"Clin Cancer Res"},{"key":"1104_CR39","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.1016\/j.semcancer.2015.09.007","volume":"35","author":"KI Block","year":"2015","unstructured":"Block KI, et al. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 2015;35:S276\u2013304.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"1104_CR40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3109\/07357907.2013.830736","volume":"31","author":"A Bentke","year":"2013","unstructured":"Bentke A, Ma\u0142ecki J, Ostrowska B, Krzykowska-Petitjean K, Laidler P. Tanespimycin and tipifarnib exhibit synergism in inducing apoptosis in melanoma cell lines from later stages of tumor progression. Cancer Invest. 2013;31(8):545\u20139.","journal-title":"Cancer Invest"},{"issue":"1","key":"1104_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.01.005","volume":"319","author":"YY Zaytsevaa","year":"2012","unstructured":"Zaytsevaa YY, Valentinoa JD, Gulhatic P, Evers BM. mTOR inhibitors in cancer therapy. Cancer Lett. 2012;319(1):1\u20137.","journal-title":"Cancer Lett"},{"key":"1104_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12032-017-1069-0","volume":"35","author":"D Cio\u0142czyk-Wierzbicka","year":"2018","unstructured":"Cio\u0142czyk-Wierzbicka D, Gil D, Laidler P. Treatment of melanoma with selected inhibitors of signaling kinases effectively reduces proliferation and induces expression of cell cycle inhibitors. Med Oncol. 2018;35:7. \n                    https:\/\/doi.org\/10.1007\/s12032-017-1069-0\n                    \n                  .","journal-title":"Med Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-018-1104-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1104-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1104-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T23:21:08Z","timestamp":1551309668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-018-1104-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s12032-018-1104-9","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]},"assertion":[{"value":"9 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}],"article-number":"42"}}